Is the Mortality Benefit With Empagliflozin in Type 2 Diabetes Mellitus Too Good To Be True?

被引：18
|
作者：
Kaul, Sanjay [1 ]
机构：
[1] Cedars Sinai Med Ctr, Div Cardiol, 8635 W Third St,Ste 790W, Los Angeles, CA 90048 USA
来源：
CIRCULATION | 2016年 / 134卷 / 02期
关键词：
clinical trial; diabetes mellitus; mortality; TRIAL;
D O I：
10.1161/CIRCULATIONAHA.116.022537
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：94 / +
页数：11
相关论文
共 50 条
  • [21] Empagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
    Scott, Lesley J.
    DRUGS, 2014, 74 (15) : 1769 - 1784
  • [22] Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
    Lee-Lee Lai
    Shireene Ratna Vethakkan
    Nik Raihan Nik Mustapha
    Sanjiv Mahadeva
    Wah-Kheong Chan
    Digestive Diseases and Sciences, 2020, 65 : 623 - 631
  • [23] EMPAGLIFLOZIN: A NEW TREATMENT OPTION FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Dailey, G. E.
    DRUGS OF TODAY, 2015, 51 (09) : 519 - 535
  • [24] Empagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
    Lesley J. Scott
    Drugs, 2014, 74 : 1769 - 1784
  • [25] Depression and Mortality in Type 2 Diabetes Mellitus
    Lee, Seo Young
    Choi, Sung Hee
    DIABETES & METABOLISM JOURNAL, 2017, 41 (04) : 263 - 264
  • [26] Perinatal mortality in Type 2 diabetes mellitus
    Cundy, T
    Gamble, G
    Townend, K
    Henley, PG
    MacPherson, P
    Roberts, AB
    DIABETIC MEDICINE, 2000, 17 (01) : 33 - 39
  • [27] A review of mortality in type 2 diabetes mellitus
    Asfandiyarova, N. S.
    DIABETES MELLITUS, 2015, 18 (04): : 12 - 21
  • [28] 2 TAX SCHEMES THAT ARE TOO GOOD TO BE TRUE
    BECK, LC
    KALOGREDIS, VJ
    DELAWARE MEDICAL JOURNAL, 1977, 49 (05) : 312 - 314
  • [29] Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus
    El-Haggar, Sahar Mohamed
    Hafez, Yasser Mostafa
    El Sharkawy, Amira Mohamed
    Khalifa, Maha
    MEDICINA CLINICA, 2024, 163 (02): : 53 - 61
  • [30] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA
    Rodriguez, L.
    Lew, D.
    VALUE IN HEALTH, 2020, 23 : S115 - S115
12345